Fact sheet: Polar Capital Healthcare Opp

Fund information
Fund name
Polar Capital Healthcare Opportunities I USD
Fund manager company
Polar Capital
Fund type
OEIC
Fund managers
  • Gareth Powellsince 03/12/2007
  • Dan Mahonysince 03/12/2007
Fund objective
The Fund aims to preserve capital and achieve long-term growth by investing in a globally-diversified portfolio of companies within the healthcare industry.
Benchmark
  • MSCI Global Health Care Index
Investment style
Active,Growth
Investment method
Shares
Quick stats
1 Year return
-0.3%
1 Year rank in sector
-
Sector
FO Equity - Pharma Health & Biotech
Yield
-
Ongoing charge (OCF)
?A fund’s ongoing charges figure (OCF) is similar to the old-style total expense ratio. It reflects the annual charge to investors in the fund, in percentage terms, but does not include extra performance-related fees (where these are levied) or the fund’s trading expenses on its underlying investments.
1.16%
Fund size
£907m (£1,130m last year)
FE Risk score
?FE Risk Scores measure the riskiness of instruments relative to the FTSE 100 index of shares. Weekly volatility is measured over three years with recent behaviour counting more heavily than earlier behaviour. Cash-type investments will have scores close to zero. Funds will tend to have scores in the 0-150 range. The FTSE 100 is always scored at 100. There is no upper limit.
119
Top in this sector
Fund name1 Year
Variopartner SICAV MVGbMdtcF26.6%
BB Medtech25.8%
Fidelity Gbl Health Care23.2%
Pictet Health20.7%
Charlemagne MagnaBiphrm19.1%
...more in FO Equity - Pharma Health & Biotech

Performance snapshot

Holdings snapshot

  • USA71.3%
    Ireland8.5%
    Germany7.4%
    Switzerland5.9%
    UK3.6%
  • Pharmaceuticals33.2%
    Healthcare & Medical Products23.6%
    Biotechnology/Medical23.1%
    Health Care19.1%
    Conglomerates3%
  • US Equities71.3%
    Irish Equities8.5%
    German Equities7.4%
    Swiss Equities5.9%
    UK Equities3.6%

Performance vs Sector

Cumulative performance
 1 mth3 mth6 mth1 yr3 yr5 yr
Fund1.8%8.3%10.7%-0.3%45.7%168.6%
Sector3.4%10.6%13.1%2.8%42.1%134.3%
Rank within sector------
Quartile
Calendar performance
 YTD - 20162015201420132012
Fund-4.1%7.2%26.9%55.8%25.2%
Sector-3.1%7.2%28.1%41%16.7%
Rank within sector-----
Quartile
Risk statistics
Alpha
?Alpha is a measure of a fund's over- or under-performance by comparison to its benchmark. If the Alpha is 5, the fund has outperformed its benchmark by 5%; so the greater the Alpha, the greater the outperformance.
3.87
Beta
?Beta estimates a fund's volatility by comparison to that of its benchmark. A fund with a beta close to 1 means that the fund will move generally in line with the benchmark. Higher than 1 and the fund is more volatile than the benchmark and vice versa.
0.89
Sharpe
?This commonly-used measure calculates the level of return over and above the return of a notional risk-free investment, such as cash. The difference in returns is then divided by the fund's volatility. The resulting ratio is an indication of the amount of excess return generated per unit of risk.
0.72
Volatility
?Volatility (or standard deviation), when applied to an investment fund, expresses its risk. It shows how widely a range of returns varied from the fund's average return over a particular period. For example, if a fund had an average return of 5%, and its volatility was 15, this would mean that the range of its returns over the period had swung between +20% and -10%.
16.47
Tracking error
?This measures the standard deviation of a fund's excess returns over the returns of an index or benchmark portfolio. As such, it can be an indication of 'riskiness' in the manager's investment style. A Tracking Error below 2 suggests a passive approach. At 3 and above the the manager will be deploying a more active investment style.
8.46
Information ratio
?This is a useful risk-adjusted measure of actively managed fund performance. It is calculated by deducting the returns of the fund's benchmark from the fund's overall returns, then dividing the result by its tracking error. The higher the Information Ratio the better. It is generally considered that a figure of 0.5 reflects a good performance, 0.75 very good, and 1.00 outstanding.
0.27
R-Squared
?An indication of how closely correlated a fund is to an index or a benchmark. Values for R-Squared range between 0 and 1, with 0 indicating no correlation at all and 1 showing a perfect match. Values upwards of 0.7 suggest that the fund's behaviour is increasingly linked to its benchmark.
0.74
Price movement
52 week high39.35
52 week low31.87
Current bid price-
Current offer price-
Current mid price36.99
Region
1USA71.3%
2Ireland8.5%
3Germany7.4%
4Switzerland5.9%
5UK3.6%
6Denmark2.4%
7Belgium1.7%
8Money Market-0.8%
Industry sector
1Pharmaceuticals33.23%
2Healthcare & Medical Products23.57%
3Biotechnology/Medical23.09%
4Health Care19.05%
5Conglomerates2.96%
6Money Market-1.89%
Asset type
1US Equities71.3%
2Irish Equities8.5%
3German Equities7.4%
4Swiss Equities5.9%
5UK Equities3.6%
6Danish Equities2.4%
7Belgian Equities1.7%
8Money Market-0.8%
Individual holdings
1PFIZER INC6.93%
2NOVARTIS AG5.89%
3AMGEN INC4.11%
4BRISTOL-MYERS SQUIBB CO3.88%
5FRESENIUS MEDICAL CARE AG & CO.KGAA3.63%
6MERCK KGAA3.61%
7BIOMARIN PHARMACEUTICAL3.41%
8SHIRE PLC3.39%
9CELGENE CORP3.2%
Management
Fund manager group
Polar Capital
Fund manager company
Polar Capital
Fund type
OEIC
Fund objective
The Fund aims to preserve capital and achieve long-term growth by investing in a globally-diversified portfolio of companies within the healthcare industry.
Benchmark
  • MSCI Global Health Care Index
Investment style
Active,Growth
Investment method
Shares
Fund managers
NameSinceBiography
Gareth Powell03/12/2007Gareth joined Polar Capital in 2007 to set up the healthcare team. He has over 15 years’ investment experience in the healthcare sector, with 11 years as a Portfolio Manager. He joined Framlington in 1999 becoming a Portfolio Manager on the Framlington health fund. In 2002, he helped launch and then run the Framlington biotech fund. Gareth became a CFA charterholder in 2003. Gareth studied biochemistry at Oxford from 1995 to 1999 and during that time worked at Astellas, the Sir William Dunn School of Pathology, the Wolfson Institute for Biomedical Research and the Oxford Business School.
Dan Mahony03/12/2007Daniel joined Polar Capital to set up the healthcare team in 2007. He has 23 years of industry experience, comprising more than 16 years’ investment experience in the healthcare sector, with over seven years as a Portfolio Manager and nine years as a sell-side analyst. Prior to joining Polar Capital, he was head of the European healthcare research team at Morgan Stanley, covering the European biotechnology, medical technology and healthcare services sectors. He also previously worked in New York for ING Barings Furman Selz following the US biotechnology sector. Before working in the investment field, Daniel worked as a research scientist for seven years with the majority of his time at Schering Plough Corporation in California. Daniel received his PhD from Cambridge University in 1995 and a first class honours degree in biochemistry from Oxford University in 1991.
Compliance
Transparent for Austrian Tax, Transparent for Swiss Tax, Distributor Status, IA Recognised, Reporting Fund Status, UCITS IV Compliant
Domicile
No data available.
Fund for sale in
Austria, Belgium, Switzerland, Germany, Denmark, Spain, Finland, France, United Kingdom, Guernsey, Ireland, Italy, Jersey, Luxembourg, Netherlands, Norway, Offshore, Singapore, Sweden
Polar Capital Healthcare Opportunities EUR
Initial charge5%
Annual charge1.5%
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)1.66%
Total expense ratio (TER)1.71%
Bid price-
Offer price-
Mid price22.32
CurrencyEUR
Price updated27/09/2016
TypeIncome
Institutional or retail classRetail
Domicile-
Citi codeBDN1
Polar Capital Healthcare Opportunities GBP
Initial charge5%
Annual charge1.5%
Min single investment£0
Min regular saving£0
Available in ISAYes
Ongoing charge (OCF)1.66%
Total expense ratio (TER)1.71%
Bid price-
Offer price-
Mid price19.24
CurrencyGBP
Price updated27/09/2016
TypeIncome
Institutional or retail classRetail
Domicile-
Citi codeBDN0
Polar Capital Healthcare Opportunities I EUR
Initial charge5%
Annual charge1%
Min single investment£1,000,000
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)1.16%
Total expense ratio (TER)1.21%
Bid price-
Offer price-
Mid price33.03
CurrencyEUR
Price updated27/09/2016
TypeIncome
Institutional or retail classInstitutional
Domicile-
Citi codeGLG7
Polar Capital Healthcare Opportunities I GBP
Initial charge5%
Annual charge1%
Min single investment£1,000,000
Min regular saving£0
Available in ISAYes
Ongoing charge (OCF)1.16%
Total expense ratio (TER)1.21%
Bid price-
Offer price-
Mid price28.49
CurrencyGBP
Price updated27/09/2016
TypeIncome
Institutional or retail classInstitutional
Domicile-
Citi codeGLG6
Polar Capital Healthcare Opportunities I USD
Initial charge5%
Annual charge1%
Min single investment£1,000,000
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)1.16%
Total expense ratio (TER)1.21%
Bid price-
Offer price-
Mid price36.99
CurrencyUSD
Price updated27/09/2016
TypeIncome
Institutional or retail classInstitutional
Domicile-
Citi codeGLG5
Polar Capital Healthcare Opportunities R EUR
Initial charge5%
Annual charge1.5%
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)1.66%
Total expense ratio (TER)1.71%
Bid price-
Offer price-
Mid price31.9
CurrencyEUR
Price updated27/09/2016
TypeIncome
Institutional or retail classRetail
Domicile-
Citi codeGLH0
Polar Capital Healthcare Opportunities R GBP
Initial charge5%
Annual charge1.5%
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)1.66%
Total expense ratio (TER)1.71%
Bid price-
Offer price-
Mid price27.51
CurrencyGBP
Price updated27/09/2016
TypeIncome
Institutional or retail classRetail
Domicile-
Citi codeGLG9
Polar Capital Healthcare Opportunities R USD
Initial charge5%
Annual charge1.5%
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)1.66%
Total expense ratio (TER)1.71%
Bid price-
Offer price-
Mid price35.72
CurrencyUSD
Price updated27/09/2016
TypeIncome
Institutional or retail classRetail
Domicile-
Citi codeGLG8
Polar Capital Healthcare Opportunities USD
Initial charge5%
Annual charge1.5%
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)1.66%
Total expense ratio (TER)1.71%
Bid price-
Offer price-
Mid price24.99
CurrencyUSD
Price updated27/09/2016
TypeIncome
Institutional or retail classRetail
Domicile-
Citi codeBDM9
Data provided by

The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Moneywise and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.

This information is sourced from our partner Financial Express. We believe the data to be correct however you should take care in using any information.

You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.